How is the Eterna Therapeutics Inc today?

The Eterna Therapeutics Inc today is trading in the down by -18.18% at 0.18.

What is Eterna Therapeutics Inc Annual Revenue?

Eterna Therapeutics Inc Annual Revenue rose 755.88%, in the last year to $0.58 M. Its sector's average revenue growth for the last fiscal year was 4.26%.

What is Eterna Therapeutics Inc Annual Net Profit?

Eterna Therapeutics Inc Annual Net Profit fell 105.55% in the last year to $44.54 M. Its sector's average net profit growth for the last fiscal year was 29.37%.

What is Eterna Therapeutics Inc Price to Earning Ratio?

Eterna Therapeutics Inc Price to Earning Ratio is -0.24, which is negative.

What is Eterna Therapeutics Inc Stock Price?

Eterna Therapeutics Inc Stock Price fell 90.53% and underperformed its sector by 125.48% in the past year.

What is Eterna Therapeutics Inc Quarterly Net profit?

Eterna Therapeutics Inc Quarterly Net profit fell 23.39% YoY to $8.2 M. Its sector's average net profit growth YoY for the quarter was 20.98%.

What is Eterna Therapeutics Inc Debt to Equity Ratio?

Eterna Therapeutics Inc Debt to Equity Ratio of 0.4 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Eterna Therapeutics Inc Return on Equity(ROE)?

Eterna Therapeutics Inc Return on Equity(ROE) for the last financial year was -2,266.28%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Eterna Therapeutics Inc Mutual Fund Holding?

Eterna Therapeutics Inc Mutual Fund Holding decreased by 0.01% in the last quarter to 0.98.

What is Eterna Therapeutics Inc Interest Coverage Ratio?

Eterna Therapeutics Inc Interest Coverage Ratio is -5.59, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Eterna Therapeutics Inc Institutional Holding?

Eterna Therapeutics Inc Institutional Holding increased by 0.43% in the last quarter to 2.09.

Eterna Therapeutics Inc XNAS: ERNA

Eterna Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Eterna Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Eterna Therapeutics Inc
Rating: 0.56258325
Author: Trendlyne DVM scores

about

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluri...

0.18 -0.04 (-18.18%)

93.13% Fall from 52W High

1.9M XNAS Volume

High volume+loss today

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.8 / 100

Technically Bearish

21.7 / 100

No estimates available

Eterna Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Eterna Therapeutics Inc FAQ

How is Eterna Therapeutics Inc today?

Eterna Therapeutics Inc today is trading in the red, and is down by -18.18% at 0.18.

How has Eterna Therapeutics Inc performed historically?

Eterna Therapeutics Inc is currently trading down -18.18% on an intraday basis. In the past week the stock fell -21.74%. stock has been down -40.00% in the past quarter and fell -90.53% in the past year. You can view this in the overview section.